CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma

• DOI: 10.6004/jnccn.2024.7215
• Publication Date: 2025-03-28T14:33:23Z
• Authors: Honghui Huang; Fei Li; Yan Xu; Wenming Chen; Guangxun Gao; Zhongjun Xia; Xiaobing Huang; Jun Luo; Xiaoling Guo; Chunrui Li; Chunyan Sun; Baijun Fang; Fengyan Jin; Yongqian Jia; Shuhao Mei; Juan Du; Rong Zhan; Zhen Cai; Luqun Wang; Hongming Huang; Hongfeng Ge; Xiuhua Han; Jian Hou
• Keywords: Denosumab; Bone disease; Multicenter trial

"CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment Bone Disease Patients Multiple Myeloma" published on 28 Mar 2025 by National Comprehensive Cancer Network.